Certainties and uncertainties about Alzheimer ’s funding

I visited Cleveland over Thanksgiving. In a moment of peace from family conversations, I picked up the local paper. The first story I encountered was a long report on the Health and Retirement Study findings, funded by NIA, showing a substantial decline in U.S. dementia rates in the last 20 years. Then, I encountered a story reporting Eli Lilly’s negative clinical trial results on solanezumab. My immediate conclusion was that, no matter where I go, my job follows me!

Source: Inside NIA: A Blog for Researchers - November 30, 2016 Category: Geriatrics Authors: Robin Barr, Director of the Division of Extramural Activities Source Type: blogs